Kegel exercise

LevLane Advertising Named as Finalist in PRSA Anvil Awards

Retrieved on: 
Tuesday, March 12, 2024
PR, Health, Vulva, Vagina, Feature article, OBGYN, Tactic, Meta, Woman, Kegel exercise, Advertising, Marketing, PRSA

PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising , one of Philadelphia's oldest independent full-service advertising agencies, has been named a finalist for the prestigious Public Relations Society of America's (PRSA) 2024 Anvil Awards.

Key Points: 
  • PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising , one of Philadelphia's oldest independent full-service advertising agencies, has been named a finalist for the prestigious Public Relations Society of America's (PRSA) 2024 Anvil Awards.
  • The Anvil Awards recognize the best public relations tactics and campaigns of the year and represent the highest standards of performance in the industry.
  • LevLane's entry for the "Feature Article" category showcased the team's collaboration with Dr. Karla Loken, DO, OBGYN, FACOOG, addressing the gender biases present in women's health advertising.
  • The project team included: Liz Weir, chief marketing officer (LevLane); Kevin Dunn, chief client officer (LevLane); Lauren Stralo, PR supervisor (LevLane); Lauren Hepburn, PR specialist (LevLane); Kelly Ryan, account team (LevLane); Katie Gavin, project management (LevLane); Michele Burns, project team (LevLane); and Dr. Karla Loken, DO, OBGYN, FACOOG, medical affairs.

Axena Health welcomes 4 distributors for the Leva Pelvic Health System

Retrieved on: 
Tuesday, January 9, 2024
Women, Seniors, General Health, Health, Medical Devices, Consumer, Clinical Trials, Other Health, Woman, Patient, NAFC, Continence, Female, Fecal incontinence, PFMT, Urinary incontinence, Embarrassment, Kegel exercise, Quality of life, Incontinence, Accidental, National Association for Continence, UI, FDA, Doctor of Philosophy, Shame, Pelvic floor, Physician

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has signed agreements with four leading distributors to streamline access to the Leva® Pelvic Health System.

Key Points: 
  • Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has signed agreements with four leading distributors to streamline access to the Leva® Pelvic Health System.
  • While UI and FI are the most prevalent pelvic floor disorders among women, they are vastly undertreated.
  • The Leva System makes PFMT accessible by supporting a women’s success as she improves her incontinence symptoms.
  • "Pelvic floor muscle training is a globally recommended solution that Leva makes more accessible to women.

Total Health Link Leads the Charge in At-Home Health Practices: Burlington's Premier Chiropractic and Physiotherapy Experts Share Home Health Tips

Retrieved on: 
Monday, November 6, 2023
Low back pain, Leg, Massage, Incontinence, Knee, The, Computer, Hip, Human, Calf, Abdomen, Foot, Sports equipment, Poultry farming, Kegel exercise, BURLINGTON, Acupuncture

Psoas Stretch: In a lunge position, with one knee on the ground, tilt your pelvis forward to stretch the front of your hip on the kneeling side.

Key Points: 
  • Psoas Stretch: In a lunge position, with one knee on the ground, tilt your pelvis forward to stretch the front of your hip on the kneeling side.
  • Hamstring Stretch: Seated on the ground, extend one leg out and reach toward your toes while keeping your back straight.
  • Glute Stretch: While seated, cross one ankle over the opposite knee and gently press down on the crossed knee.
  • Pelvic Tilts: Lying on your back with knees bent, flatten your back against the floor by tightening your abdominal muscles and tilting your pelvis.

Axena Health celebrates “Best Overall” abstract showing the Leva System’s long-term efficacy for female urinary incontinence

Retrieved on: 
Thursday, June 22, 2023
Medical Devices, Women, FDA, Health Technology, Biotechnology, Managed Care, Health, Consumer, General Health, University, UI, European Journal of Obstetrics & Gynecology and Reproductive Biology, Prevalence, PFMT, Storey, RCT, The Hague, Incontinence, Quality of life, Woman, FI, Leva, FACOG, Associate, Reproductive biology, Harvard Medical School, MD, Randomized controlled trial, Gynaecology, Chairperson, FACS, Hospital, Massachusetts General Hospital, Pelvic floor dysfunction, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Female, Urinary incontinence, Birth control, Pharmaceutical industry, Kegel exercise

As a prescription medical device, the Leva System enables supervised PFMT, which level one evidence shows is most effective.

Key Points: 
  • As a prescription medical device, the Leva System enables supervised PFMT, which level one evidence shows is most effective.
  • The IUGA abstract affirms that UI symptom improvement from just eight weeks of treatment with the Leva System lasts at least 24-months.
  • “More than 60 percent of adult women in the United States experience urinary incontinence,” said Samantha Pulliam, M.D., Axena Health’s Chief Medical Officer.
  • In May 2023, Axena Health announced a large-scale study into the burdens of incontinence on women in low- and middle-income countries.

Peeing when laughing? It is time to get your pelvic floor in order with the physical therapist's help and a training device

Retrieved on: 
Wednesday, June 14, 2023
Exercise, Pelvic pain, Education, Urine, Taboo, Weakness, Constipation, Woman, Incontinence, Research, Pelvic floor, Cough, Physical examination, Vulvodynia, Thought, Masturbation, Pain, Hyperkinesia, Motion, Patient, Sneeze, Stress incontinence, Ageing, Kegel exercise, Urinary incontinence, Pelvic floor dysfunction, Pelvic floor physical therapy, Birth control

NEW YORK, June 14, 2023 /PRNewswire/ -- Pelvic floor exercise or Kegel exercise is a popular topic today, but although many women have heard about these exercises, much education is still needed to fully understand the pelvic floor and the impact it can have on intimate health. As the brand that carries a mission to educate and empower women and break taboos surrounding women's bodies, INTIMINA answers about the pelvic floor and Kegel exercise - with the help of Rachel Gelman, a Pelvic Floor Physical Therapist.

Key Points: 
  • As the brand that carries a mission to educate and empower women and break taboos surrounding women's bodies, INTIMINA answers about the pelvic floor and Kegel exercise - with the help of Rachel Gelman, a Pelvic Floor Physical Therapist.
  • But most are unaware that this is a symptom of pelvic floor dysfunction which can be cured.
  • One of the cures is Kegel exercises, which, when performed correctly, can help strengthen the pelvic floor muscles.
  • According to research , vibratory stimulation can improve pelvic floor muscle strength and help conditions such as vulvodynia and incontinence.

Axena Health Receives Positive Insurance Coverage Decision From Cigna Healthcare for Leva Pelvic Health System

Retrieved on: 
Wednesday, March 22, 2023
Insurance, Medical Devices, Women, Professional Services, Health Insurance, Other Health, Health, Consumer, General Health, UI, Obstetrics, NAFC, PFMT, Policy, Food and Drug Administration, RCT, Ageing, Continence, PDT, Woman, FI, Leva, FACOG, Privacy, Pelvic floor, MD, Patient, Standard of care, Overactive bladder, Gynaecology, FDA, Kegel exercise, News, Food, Female, Urinary incontinence, Birth control, Nursing, Cigna

Axena Health, Inc. (Axena Health), a medical device company relentlessly dedicated to women’s health, today announced that Cigna Healthcare (Cigna), one of the largest healthcare insurance providers in the United States with approximately 15 million members, has added the Leva Pelvic Health System as a covered treatment for stress, urgency and mixed urinary incontinence (UI) in women.

Key Points: 
  • Axena Health, Inc. (Axena Health), a medical device company relentlessly dedicated to women’s health, today announced that Cigna Healthcare (Cigna), one of the largest healthcare insurance providers in the United States with approximately 15 million members, has added the Leva Pelvic Health System as a covered treatment for stress, urgency and mixed urinary incontinence (UI) in women.
  • The positive coverage decision from Cigna follows Axena Health’s recent $25 million Series A fundraising and a new Obstetrics and Gynecology study showing the Leva System’s long-term efficacy for female UI.
  • For our patients, the Leva System makes this training easy, accessible and effective, allowing more women to live leak-free.
  • Cigna’s coverage policy update then states, “a newer at-home biofeedback device and remotely delivered program called Leva® Pelvic Health System was developed to mitigate some of these issues.

Axena Health Commends Obstetrics and Gynecology Publication Showing Leva® Pelvic Health System’s Long-Term Efficacy for Female Urinary Incontinence

Retrieved on: 
Wednesday, March 1, 2023
Health, Medical Devices, Consumer, Women, Clinical Trials, Research, Science, Medicine, Overactive bladder, American College, RCT, FI, Associate, The Green Journal, PFMT, Randomized controlled trial, Pelvic floor dysfunction, Massachusetts General Hospital, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, ACOG, American College of Obstetricians and Gynecologists, AXA, Harvard Medical School, Kegel, Hospital, Urinary incontinence, MUI, Leva, Woman, Reproductive biology, Literature, SUI, Food, UI, PDT, Birth control, Pharmaceutical industry, Kegel exercise, Gynaecology, Obstetrics

The Leva Pelvic Health System (the Leva System) is a prescription digital therapeutic (PDT) that offers easy-to-use, at-home treatment for urinary and chronic fecal incontinence (FI) in women.

Key Points: 
  • The Leva Pelvic Health System (the Leva System) is a prescription digital therapeutic (PDT) that offers easy-to-use, at-home treatment for urinary and chronic fecal incontinence (FI) in women.
  • Of the 299 participants, women using the Leva System experienced durable, significantly greater improvement in UI symptoms compared with women who relied on Kegels alone.
  • The 2023 publication announced today shows that UI symptom improvement lasts, even without ongoing use of the Leva System.
  • “Urinary incontinence is common, but it should not be normal,” said Eileen Maus, CEO of Axena Health.

Published studies find low documented adherence to guideline-based care for female urinary incontinence

Retrieved on: 
Friday, July 22, 2022
Diagnosis, Obstetrics & Gynecology (journal), Instagram, Use, UI, Adult, SUFU, Cough, LinkedIn, American Urological Association, American College of Obstetricians and Gynecologists, AUA, American College, Obstetrics, Smartphone, Research, Woman, PFMT, Solution, Pelvic floor, Medical Affairs Bureau, Society, Urinary incontinence, Doctor of Pharmacy, All rights reserved, Storey, Engineering, Physician, Overactive bladder, Twitter, Female, ACOG, Sexual dysfunction, Health, Femtech, Quality of life, PDT, FDA, DPT, MUI, FI, Exertion, SUI, Sneeze, Feces, Time, MPH, Urine, Hotel manager, Rehabilitation, Physical, Movement, Mental health, Senior, Patient, PT, Medical device, Medical imaging, Health insurance, Birth control, Gynaecology, Kegel exercise, Gynaecology, Facebook, Urodynamic testing

BOSTON, July 22, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a developer of non-surgical treatments for female pelvic floor disorders and an advocate for women's health, announced today that Neurourology and Urodynamics published two studies demonstrating low rates of documented adherence to treatment guidelines for female urinary incontinence (UI) care for women and the effect on payer costs. One study showed significantly higher costs for payers in the two years following diagnosis for women whose treatment claims did not align with published guidelines for female UI. A second study showed very low use of physical therapy (PT) for UI, a discipline commonly engaged in first-line care for UI.

Key Points: 
  • BOSTON, July 22, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a developer of non-surgical treatments for female pelvic floor disorders and an advocate for women's health, announced today that Neurourology and Urodynamics published two studies demonstrating low rates of documented adherence to treatment guidelines for female urinary incontinence (UI) care for women and the effect on payer costs.
  • A second study showed very low use of physical therapy (PT) for UI, a discipline commonly engaged in first-line care for UI.
  • Numerous studies show PFMT isan effective treatment for urinary incontinence and that PFMT, commonly referred to as Kegels, is challenging for women to implement effectively on their own.
  • The study determined that documented care not sequenced in adherence to guidelines increasedpayers' cost burden.

Published health economics study shows improved treatment for female urinary incontinence may have positive effect on patient outcomes and healthcare costs

Retrieved on: 
Tuesday, June 21, 2022
PT, Rehabilitation, Cough, Pelvic floor, Smartphone, LinkedIn, Obstetrics, Urine, University, Keck School of Medicine of USC, Health, MUI, Associate, Urinary incontinence, Division, Obstetrics & Gynecology (journal), Incontinence, Therapy, Female, UI, Use, Storey, PDT, Sneeze, Twitter, Movement, PFMT, FDA, Urogynecology, All rights reserved, Medical Affairs Bureau, Sexual dysfunction, Exertion, SUI, Adult, Patient, Multimedia, Instagram, Woman, Safety, Research, Kegel exercise, Overactive bladder, Femtech, Pharmaceutical industry, Health insurance, Birth control, Medical imaging, Gynaecology, Urodynamic testing, Medicine, Facebook

BOSTON, June 21, 2022 /PRNewswire/ -- Renovia Inc. (Renovia), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that a recent peer-reviewed, published study showed that women with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) consume significantly more medical resources and incur higher costs to payers, compared to women without SUI/MUI.  The study was published in Neurourology and Urodynamics, the official journal of the Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction.

Key Points: 
  • The study was published in Neurourology and Urodynamics , the official journal of the Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction.
  • The study, "Healthcare Resource Use and Cost Burden of Urinary Incontinence to United States Payers," assessed healthcare resource utilization and costs for female patients diagnosed with stress or mixed urinary incontinence (SUI/MUI) compared to a 1:1 matched cohort of patients without SUI/MUI.
  • Urinary incontinence (UI) is a highly prevalent health condition experienced by over 60% of adult women.
  • Multiple studies show that Pelvic Floor Muscle Training (PFMT), commonly referred to as Kegel exercises, can offer effective, first-line treatment for urinary incontinence.

Renovia debuts "Stronger Women" campaign at annual gathering of women's health care leaders

Retrieved on: 
Friday, May 6, 2022
PDT, Rehabilitation, Loneliness, American College, University, University of New Mexico, Instagram, Twitter, Femtech, Woman, ACOG, Smartphone, Physician, Massachusetts General Hospital, Shame, Research, PFMT, Use, Storey, Patient, Sexual dysfunction, ACSM, Obstetrics & Gynecology (journal), University of Alabama, Kegel exercise, FDA, Urinary incontinence, Therapy, M.D, Overactive bladder, Adult, Health, Randomized controlled trial, Movement, LinkedIn, Female, UI, Harvard Medical School, Science, Pelvic floor, CEO, SAN, Obstetrics, Obstetrics and gynaecology, All rights reserved, American College of Obstetricians and Gynecologists, Taboo, Digital, Birth control, Pharmaceutical industry, Gynaecology, Facebook

SAN DIEGO, May 6, 2022 /PRNewswire/ -- ACOG Annual Meeting — Renovia Inc. (Renovia), a women-led company that develops digital therapeutics for female pelvic floor disorders, has launched a new brand campaign titled, Stronger Women, at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM). The campaign is intended to educate clinicians and women about urinary incontinence (UI) and the leva® Pelvic Health System, a convenient, easy-to-use, at-home pelvic health program that can help women strengthen their pelvic floor and decrease the symptoms of stress, mixed and mild to moderate UI, including overactive bladder. Through the campaign, and by launching it at the ACSM, Renovia seeks to make first-line treatment for UI more accessible and accelerate the momentum supporting regular screening for female UI among clinicians.

Key Points: 
  • The Stronger Women campaign centers on the importance of a strong pelvic floor in women's overall health and well-being.
  • The campaign also humanizes the issues associated with UI and, thus, seeks to make UI less taboo.
  • "While ACOG recommends annual screening for UI, treatment options often require drugs, surgery or access to physical therapy.
  • Renovia Inc. and levaare trademarks or registered trademarks of Renovia Inc. in the United States and other countries.